GB

Geoff Birkett

Chief Commercial Officer

Ensysce Biosciences

Ensysce Biosciences Pipeline

DrugIndicationPhase
PF614Management of severe painPhase 2
PF614-MPARManagement of severe pain with overdose protectionPhase 2
PF650Management of severe pain in opioid-tolerant patientsPhase 1